LABORATORY
Located in the San Francisco Bay Area in Menlo Park, CA Optivia’s state-of-the-art laboratory facility includes a team of scientists with in-depth experience in developing in vitro transporter models and using them for drug discovery and development. Optivia’s cutting edge transporter research is funded in part by NIH SBIR grants.
Located in the San Francisco Bay Area in Menlo Park, CA Optivia’s state-of-the-art laboratory facility includes a team of scientists with in-depth experience in developing in vitro transporter models and using them for drug discovery and development. Optivia’s cutting edge transporter research is funded in part by NIH SBIR grants.
STUDIES
Drug discovery and development scientists rely on information from our studies for drug-drug interaction assessments and to design compounds with increased bio-availability and targeted tissue distribution.
Drug discovery and development scientists rely on information from our studies for drug-drug interaction assessments and to design compounds with increased bio-availability and targeted tissue distribution.
The Advisory Committee’s position will impact drug development immediately. Not only has the FDA made its intentions clear, but partners have been asking for transporter studies during due diligence.
-- Peter Milner, M.D., President and
co-founder of ARYx Therapeutics
Download the ITC Transporter White Paper Road Map: a bullet point summary.
-- Peter Milner, M.D., President and
co-founder of ARYx Therapeutics
Download the ITC Transporter White Paper Road Map: a bullet point summary.
Optivia Biotechnology conducts in vitro transporter assays modeled on human biology. We provide DMPK research teams with FDA-ready reports. Our proprietary technology allows us to deliver results fast. Unlike other labs, we have the complete set of seven FDA transporters and we are the only company to provide those in polarized mammalian cells.
Optivia Transporter Webinar
July 27, 2010:
Dr. Yuichi Sugiyama
"Membrane Transporters
in Drug Response"
REGISTER NOW
July 27, 2010:
Dr. Yuichi Sugiyama
"Membrane Transporters
in Drug Response"
REGISTER NOW